Licensing in the UAE
The Federal Law of the UAE No. 17 of 2002, in the Regulation and protection of industrial property for patents and industrial designs in Article 1 clearly depicts the intent of the invention for which the patent is granted and…
Musical Work Used Commercially And Its Licensing Requirements
You cannot play music for your employees or the public in an office or shop or any commercial spaces, no matter what the medium is (phone system, radio, and disc, TV, or Bluetooth speakers). Business organizations or Entities that are…
A Brief Analysis Of Compulsory Licensing Pertinent To Copyright Law
Introduction As the title suggests, this particular blog deals with the compulsory licensing of copyright in our country. However, in order to understand compulsory licensing, the concept pertinent to “licenses” needs to be grasped first. Licenses are of two categories:…
Zooming Out On Compulsory Licensing Of Covid-19 Vaccines
The unnerving bio- catastrophe, the COVID-19 pandemic has brought an array of challenges for mankind. The COVID-19 scare at the global level is posing threat to human life and the governments are deeply divided over an effort to endorse a…
Sisvel and Mitsubishi, and Xiaomi sign patent licensing deal to settle ongoing litigations
Recently, Sisvel and Mitsubishi jointly announced that the companies have entered into a patent license agreement covering the standard-essential patents (SEP) of Mitsubishi Electric and Sisvel in the field of mobile communication. This deal brings to an end the global…
DelSiTech and Visus Therapeutics enter into Patent Licensing Arrangement
Recently, DelSiTech Ltd. (“DelSiTech”), a Finland-based drug delivery company entered into a patent licensing agreement over DelSiTech’s patents with Visus Therapeutics (“Visius”), a US-based company. This is a worldwide exclusive licensing agreement. Both companies are working on six development programs…
ERS Genomics Licenses CRISPR-Cas9 patent and technology to Cellular Engineering Technologies
Recently, Dublin, Ireland-based biotechnology company, ERS Genomics Limited (“ERS”), has signed a nonexclusive license agreement with Iowa-based Cellular Engineering Technologies (“CET”) to grant access to its CRISPR-Cas9 patent portfolio. The financial terms of the agreement were not disclosed. ERS was…
Sun Pharma and Celegene Settle Patent Dispute over Lenalidomide (Revlimid®)
Settling an over three old patent infringement dispute, Indian pharmaceutical major, Sun Pharmaceuticals and its subsidiary, including US subsidiary (“Sun”), has reached a settlement with Celgene Corporation (“Celgene”), a subsidiary of pharmaceutical major Bristol Myers Squibb (BMS), to resolve and…
Bajaj Healthcare Files Compulsory License with Indian Patent Office for Baricitinib
Recently, drug manufacturer, Bajaj Healthcare Limited issued a press release stating that they have filed a compulsory license application with the Indian Patent Office seeking permission to manufacture both active pharmaceutical ingredients (raw materials) and formulation of Baricitinib under the…
Elli Lilly Enters into Licensing Deals with Indian Companies
Recently, Elli Lilly, a US-based major Pharmaceutical company, has entered into licensing agreements with a number of Indian drug manufacturers for the manufacture of and supply of Baricitinib in India which is showing promise as a drug for the treatment…